SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Yang who wrote (343)8/29/1996 11:00:00 PM
From: Richard Mazzarella   of 4342
 
Michael, PRLN has an innovative model, the method for compound response analysis, the head start in an alternative method of attack, and the compounds that cost only 1/10 of current "leading edge treatment" with less toxicity. The only way they won't be the company with the leading cure for AIDS is if they are bought out by one of the biggies. Don't underestimate the strategic partnerships that can now be formed with a leading drug company. We can "this and that" the significance of PRLN phone conference, but spectacular comes to my mind. I taped the conference if there is anything that we need to recall in the future.

Rick, I sense you have a coolness to this news. You didn't sell PRLN to buy HEC did you? I bought HEC, but also significantly increased my position in PRLN today. I don't think that the market yet understands what PRLN has accomplished. Have no doubt, it will. I just listened to a bunch of politicians saying how they want to cure AIDS. Well they can and at reasonable cost. The real need is in the 3rd world where the scourge is much worse than in the US. FDA means nothing to that market. PRLN IMO is a "pearl of great price", but having said that I am still diversified.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext